Suppr超能文献

经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干病变:G-LM 注册研究。

Percutaneous Coronary Intervention Vs Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Disease: G-LM Registry.

机构信息

Department of Cardiovascular Medicine, King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia.

Department of Cardiovascular Medicine, King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia.

出版信息

Curr Probl Cardiol. 2022 Oct;47(10):101002. doi: 10.1016/j.cpcardiol.2021.101002. Epub 2021 Sep 26.

Abstract

Coronary artery bypass surgery (CABG) has been the standard of care for revascularization for patients with obstructive unprotected left main coronary disease (ULMCA). There have been multiple randomized and registry data demonstrating the technical and clinical efficacy of PCI in certain patients with ULMCA. The purpose of this study is to evaluate clinical outcomes of ULMCA PCI as compared to CABG in patients requiring revascularization in three Gulf countries. All ULMCA cases treated by PCI with DES versus CABG were retrospectively identified from 14 centers in 3 Arab Gulf countries (KSA, UAE, and Bahrain) from January 2015 to December 2019. In total, 2138 patients were included: 1222 were treated with PCI versus 916 with CABG. Patients undergoing PCI were older, and had higher comorbidities and mean European System for Cardiac Operative Risk Evaluation (EuroSCORE). Aborted cardiac arrest and cardiogenic shock were reported more in the PCI group at hospital presentation. In addition, lower ejection fractions were reported in the PCI group. In hospital mortality and major adverse cardiovascular and cerebrovascular events (MACCE) occurred more in patients undergoing CABG than PCI. At median follow-up of 15 months (interquartile range, 30), no difference was observed in freedom from revascularization, MACCE, or total mortality between those treated with PCI and CABG. While findings are similar to Western data registries, continued follow-up will be needed to ascertain whether this pattern continues into latter years.

摘要

冠状动脉旁路移植术(CABG)一直是治疗有阻塞性无保护左主干冠状动脉疾病(ULMCA)患者血运重建的标准治疗方法。有多项随机和注册数据表明,PCI 在某些 ULMCA 患者中具有技术和临床疗效。本研究的目的是评估在需要血运重建的 3 个海湾国家的患者中,与 CABG 相比,ULMCA PCI 的临床结果。从 2015 年 1 月至 2019 年 12 月,从 3 个阿拉伯海湾国家(沙特阿拉伯、阿联酋和巴林)的 14 个中心回顾性确定了所有接受 DES 治疗的 ULMCA 患者的 PCI 病例与 CABG 的比较。共纳入 2138 例患者:1222 例接受 PCI 治疗,916 例接受 CABG 治疗。接受 PCI 治疗的患者年龄较大,合并症和平均欧洲心脏手术风险评估系统(EuroSCORE)较高。在入院时,PCI 组报告了更多的心脏骤停和心源性休克。此外,PCI 组的射血分数较低。在住院期间死亡率和主要不良心血管和脑血管事件(MACCE)在接受 CABG 的患者中比接受 PCI 的患者更常见。在 15 个月(中位数,30 个月)的中位随访中,与接受 PCI 治疗的患者相比,接受 CABG 治疗的患者在血运重建、MACCE 或总死亡率方面无差异。虽然结果与西方数据登记相似,但需要继续随访以确定这种模式是否会持续到后期。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验